Complete response to crizotinib in a metastatic adenocarcinoma of unknown primary harboring MET amplification and NTRK1 co-occurring mutation
暂无分享,去创建一个
Yan Yang | Yue Zhu | Jing-hao Yao | Lu Zhang | Y. Ou | Xiao-jing Wang | Zi-shu Wang | Anran Wang | Yu-rong Ou